Compare ANTX & MBBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANTX | MBBC |
|---|---|---|
| Founded | 2017 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.2M | 33.5M |
| IPO Year | 2022 | N/A |
| Metric | ANTX | MBBC |
|---|---|---|
| Price | $1.32 | $12.22 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 107.1K | 2.7K |
| Earning Date | 11-12-2025 | 02-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.11 |
| Revenue | N/A | ★ $7,299,708.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $103.28 |
| Revenue Growth | N/A | ★ 7.77 |
| 52 Week Low | $1.00 | $8.74 |
| 52 Week High | $1.55 | $12.89 |
| Indicator | ANTX | MBBC |
|---|---|---|
| Relative Strength Index (RSI) | 68.81 | 58.01 |
| Support Level | $1.00 | $11.75 |
| Resistance Level | $1.35 | $12.44 |
| Average True Range (ATR) | 0.08 | 0.28 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 90.60 | 74.74 |
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.
Marathon Bancorp Inc is a mid-tier holding company for Marathon Bank, a Wisconsin-chartered savings bank. The group operates as a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the group's revenue comes from interest income on loans and debt securities.